Targovax ASA: third quarter 2020 results ...Middle East

PR Newswire - News
OSLO, Norway, Nov. 5, 2020 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2020 results. An online presentation by Targovax's management to investors,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Targovax ASA: third quarter 2020 results )

Apple Storegoogle play

Also on site :



Latest News